Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial.
Saved in:
| Title: | Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial. |
|---|---|
| Authors: | Klamroth R; Internal Medicine, Vascular Medicine and Coagulation Disorders, Vivantes Clinic Friedrichshain, Berlin, Germany., Monahan PE; CSL Behring, King of Prussia, Pennsylvania, USA., Van der Valk P; Centre for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Quon D; Orthopedic Hemophilia Treatment Center, The Luskin Orthopedic Institute for Children, Los Angeles, California, USA., Kazmi RS; Department of Hematology, University Hospital Southampton National Health Service Foundation Trust, Southampton, United Kingdom., Coppens M; Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, The Netherlands., O'Connell N; National Coagulation Centre, Department of Hematology, St. James's Hospital, Dublin, Ireland.; School of Medicine, Trinity College, Dublin, Ireland., Pipe SW; Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, Michigan, USA., von Drygalski A; Division of Hematology/Oncology, Department of Medicine, University of California San Diego, San Diego, California, USA., Afzal S; ProtaGene CGT GmbH, Heidelberg, Germany., Gabriel R; ProtaGene CGT GmbH, Heidelberg, Germany., Youssar L; ProtaGene CGT GmbH, Heidelberg, Germany., Gill S; CSL Behring, King of Prussia, Pennsylvania, USA., Jansen N; CSL Behring, King of Prussia, Pennsylvania, USA., Wang F; CSL Behring, King of Prussia, Pennsylvania, USA., Le Quellec S; CSL Behring, King of Prussia, Pennsylvania, USA., Hermans C; Department of Internal Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium. |
| Source: | Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2026 Jan 19; Vol. 10 (1), pp. 103360. Date of Electronic Publication: 2026 Jan 19 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101703775 Publication Model: eCollection Cited Medium: Internet ISSN: 2475-0379 (Electronic) Linking ISSN: 24750379 NLM ISO Abbreviation: Res Pract Thromb Haemost Subsets: In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41756540 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Klamroth+R%22">Klamroth R</searchLink>; Internal Medicine, Vascular Medicine and Coagulation Disorders, Vivantes Clinic Friedrichshain, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Monahan+PE%22">Monahan PE</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Van+der+Valk+P%22">Van der Valk P</searchLink>; Centre for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Quon+D%22">Quon D</searchLink>; Orthopedic Hemophilia Treatment Center, The Luskin Orthopedic Institute for Children, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Kazmi+RS%22">Kazmi RS</searchLink>; Department of Hematology, University Hospital Southampton National Health Service Foundation Trust, Southampton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Coppens+M%22">Coppens M</searchLink>; Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22O'Connell+N%22">O'Connell N</searchLink>; National Coagulation Centre, Department of Hematology, St. James's Hospital, Dublin, Ireland.; School of Medicine, Trinity College, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Pipe+SW%22">Pipe SW</searchLink>; Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22von+Drygalski+A%22">von Drygalski A</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of California San Diego, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Afzal+S%22">Afzal S</searchLink>; ProtaGene CGT GmbH, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gabriel+R%22">Gabriel R</searchLink>; ProtaGene CGT GmbH, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Youssar+L%22">Youssar L</searchLink>; ProtaGene CGT GmbH, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gill+S%22">Gill S</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Jansen+N%22">Jansen N</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Wang+F%22">Wang F</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Le+Quellec+S%22">Le Quellec S</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Hermans+C%22">Hermans C</searchLink>; Department of Internal Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101703775%22">Research and practice in thrombosis and haemostasis</searchLink> [Res Pract Thromb Haemost] 2026 Jan 19; Vol. 10 (1), pp. 103360. <i>Date of Electronic Publication: </i>2026 Jan 19 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101703775 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2475-0379 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224750379%22">24750379 </searchLink><i>NLM ISO Abbreviation: </i>Res Pract Thromb Haemost <i>Subsets: </i>In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41756540 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.rpth.2026.103360 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 103360 Titles: – TitleFull: Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Klamroth R – PersonEntity: Name: NameFull: Monahan PE – PersonEntity: Name: NameFull: Van der Valk P – PersonEntity: Name: NameFull: Quon D – PersonEntity: Name: NameFull: Kazmi RS – PersonEntity: Name: NameFull: Coppens M – PersonEntity: Name: NameFull: O'Connell N – PersonEntity: Name: NameFull: Pipe SW – PersonEntity: Name: NameFull: von Drygalski A – PersonEntity: Name: NameFull: Afzal S – PersonEntity: Name: NameFull: Gabriel R – PersonEntity: Name: NameFull: Youssar L – PersonEntity: Name: NameFull: Gill S – PersonEntity: Name: NameFull: Jansen N – PersonEntity: Name: NameFull: Wang F – PersonEntity: Name: NameFull: Le Quellec S – PersonEntity: Name: NameFull: Hermans C IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 01 Text: 2026 Jan 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2475-0379 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: Research and practice in thrombosis and haemostasis Type: main |
| ResultId | 1 |